Efficacy of propranolol treatment in thyroid dysfunction associated with severe infantile hepatic hemangioma

Hormone Research in Paediatrics

Volumn 78, Issue 4, 2012, Pages 256-260

  Vergine, Gianluca ^a   Marsciani, Alberto ^a   Pedini, Annalisa ^a   Brocchi, Silvia ^a   Marsciani, Martino ^b   Desiderio, Elena ^c   Bertelli, Sara ^c   Vecchi, Vico ^a  

^a Laboratorio di Biologia Oncologica ed Ematologica   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c S ANNA HOSPITAL   (Italy)

Author keywords

Hepatic hemangioma; Iodothyronine deiodinase; Propranolol; Thyroid dysfunction; TSH like factor

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOSE TRANSPORTER 1; LEVOTHYROXINE; PREDNISONE; PROPRANOLOL; THYROTROPIN; THYROXINE; VINCRISTINE;

ABDOMINAL DISTENSION; ARTICLE; CAPILLARY HEMANGIOMA; CASE REPORT; CELL PROLIFERATION; CONGENITAL HYPOTHYROIDISM; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LIVER BIOPSY; LIVER HEMANGIOMA; LIVER TRANSPLANTATION; MULTIPLE CYCLE TREATMENT; NEONATAL RESPIRATORY DISTRESS SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKIN BIOPSY; SKIN HEMANGIOMA; SUBCUTANEOUS NODULE; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TUMOR VOLUME; ULTRASOUND;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEMANGIOMA; HUMANS; INFANT; LIVER NEOPLASMS; PROPRANOLOL; SEVERITY OF ILLNESS INDEX; THYROID DISEASES; TREATMENT OUTCOME;

EID: 84870402972     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000337253     Document Type: Article

References (17)

1. Christinson-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, Paltiel HJ, Klement G, Mulliken JB, Fishman SJ: Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Ped Surg 2007; 42: 62-68.
2. Bessho K, Etani Y, Ichirimori H, Namba N, Yoneda A, Ooue T, Chihara T, Morii E, Aoki T, Murakami M, Mushiake S, Ozono K: Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr 2010; 169: 215-221.
3. Guven A, Aygun C, Ince H, Aydin M, Pinarli FG, Baysal K, Küçüködük S: Severe hypothyroidism caused by hepatic hemangioendothelioma in an infant of a diabetic mother. Horm Res 2005; 63: 86-89.
4. Huang SA, Tu HM, Harney JW, Venihaki MB, Atul J, Kozakewich HPW, Fishman S, Larsen PR: Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343: 185-189.
5. Kalpatthi R, Germak J, Mizelle K, Yeager N: Thyroid abnormalities in infantile hepatic hemangioendothelioma. Pediatr Blood Cancer 2007; 49: 1021-1024.
6. Mouat F, Evans HM, Cutfield WS, Hofman PL, Jefferies C: Massive hepatic hemangioendothelioma and consumptive hypothyroidism. J Pediatr Endocrinol Metab 2008; 21: 701-703.
7. Laforgia N, Milano A, De Leo E, Bonifazi E: Emangioma e propanololo: considerazioni di fine trattamento. Differenze dai corticosteroidi. Eur J Pediat Dermatol 2009; 19: 175-191.
8. Deb G, Donfrancesco A, Ilari I, De Sio L, Milano GM, Ghitti C, Fontana G, Sandri A, Helson L: Hemangioendothelioma: successful therapy with interferon-β . Med Pediatr Oncol 2002; 38: 118-119.
9. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A: Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
10. Barnés CM, Huang S, Kaipainen A, Sanoudou D, Chen EJ, Eichler GS, Guo Y, Yu Y, Ingber DE, Mulliken JB, Beggs AH, Folkman J, Fishman SJ: Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 2005; 102: 19097-19102.
11. Ayling RM, Davenport M, Hadzic N, Metcalfe R, Buchanan CR, Howard ER, Mieli-Vergani G: Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 2001; 138: 932-935.
12. Imteyaz H, Karnsakul W, Levine MA, Burrows PE, Benson J, Hsu S, Schwarz KB: Unusual case of hypothyroidism in an infant with hepatic hemangioma. J Pediatr Gastroenterol Nutr 2012; 54: 692-695.
13. Sommers Smith SK, Smith DM: Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002; 38: 298-304.
14. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL: Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr 2010; 156: 335-338.
15. Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG, Piscione F, Priante O, Pastore L, Chiariello M, Salvatore F, Koch WJ, Trimarco B: Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005; 97: 1182-1189.
16. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G: Massive response of severe infantile hepatic hemangioma to propranolol. Pediatr Blood Cancer 2010; 54: 176.
17. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J, Ohanessian G, Léauté-Labrèze C, Labenne M, Vabres P, Rössler J, Bodemer C: Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 2010; 157: 340-342.